INS and cancer: The cause of reduced skeletal muscle glucose uptake in cancer is incompletely defined but was observed with a concurrent decrease in insulin-stimulated microvascular perfusion of muscle in tumor-bearing mice, which is similar to what has been observed in insulin-resistant obese subjects [44].